Red tide research points to cystic fibrosis therapy

Scientists at MIT have synthesized red tide toxin in what could be a significant advance toward developing new therapies to treat cystic fibrosis. Their goal was to determine the chemical machinery at work in developing the toxins which create red tide. Synthesizing brevetoxin and related compounds pointed to a potential new approach in cystic fibrosis. Brevenal acts as an antagonist to brevetoxin.

"It's very potent in what's called 'mucus movement,'" said MIT's Timothy Jamison. "That's the golden term in cystic fibrosis, from what I understand." 

- read the report from The News-Press